Anti-Rejection Drug May Boost Diabetes in Kidney Transplant Patients

Treatment with the anti-rejection drug sirolimus may leadto increased risk of diabetes inkidney transplant patients, sayresearchers who analyzed data on about 20,000 Medicare patientswho had kidney transplants ...

Comments

Comments are closed.